NeuroView Technology, Inc. — Form D
NeuroView Technology, Inc. of ENGLEWOOD, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-20. The offering totals $4.8M, of which $250K was reported sold. Industry: Other.
Offering
- Filed: 2023-12-20
- Form: D
- Accession: 0001744796-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $4.8M
- Amount sold: $250K
- Remaining: $4.6M
- Investors: 1
- Date of first sale: 2023-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-500270
Issuer
- Name: NeuroView Technology, Inc.
- CIK: 0001744796
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 101 HILLSIDE AVENUE, ENGLEWOOD, NJ, 07631
- Phone: 617-345-3000
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Werner Doyle, M.D. | Director | Englewood, NJ |
| James Karwel | Director | Englewood, NJ |
| Ruben Kuzniecky, M.D. | Director | Englewood, NJ |
| Steve Pacia, M.D. | Director | Englewood, NJ |
| Louis Rauchenberger | Director | Englewood, NJ |
| James Karwel | Executive Officer | Englewood, NJ |
| Ruben Kuzniecky, M.D. | Executive Officer | Englewood, NJ |
| Mark Goldstone | Director | San Diego, CA |
Other filings by this issuer (1)
More